The verdict
Our read at a glance.
Whether humanin's protective and metabolic biology in the lab supports the longevity and disease-prevention claims sometimes attached to it.
- The signal
- Most humanin evidence is mechanistic, from cells and animals, showing protective and metabolic effects. Human studies have mainly measured natural humanin levels and their associations with age and disease, rather than testing humanin as a treatment. There is no clinical trial evidence that taking humanin helps people.
- The unknown
- Whether humanin or its analogs can be turned into a safe and effective treatment, and whether its associations with health in observational studies reflect cause or effect.
- Our read
- A well-studied mitochondrial peptide in the lab, with no proven human use. Humanin's biology is real and studied, but the human evidence is associative, not interventional, so it should be read as a research molecule, not a therapy.
The mechanism
How it works.
Humanin is a small peptide whose coding sequence sits inside mitochondrial DNA, one of the mitochondria-derived peptides. In cell and animal studies it binds receptors on the cell surface and acts on survival and stress-response pathways, appearing to protect cells from death and to influence insulin sensitivity and metabolism. These actions are why it is studied in aging and metabolic disease, but they come almost entirely from laboratory and animal work, with human studies so far only measuring natural humanin levels rather than giving it as a treatment.
Safety & regulatory boundary
The consequential part.
Humanin is a research peptide, not an approved drug, and there is no established clinical use or human-treatment safety data. Measuring natural humanin levels in studies is not the same as administering it, and research-labeled or compounded humanin is not an approved product. Its biology does not validate longevity, metabolic, or disease-prevention claims.
What's next
What we're watching.
Any move from mechanistic and observational work toward controlled human trials of humanin or its analogs, and safety data if that happens.
Context
Why this is discussed.
Humanin is one of the best-known mitochondria-derived peptides, which makes it a focal point for interest in aging, metabolism, and cellular protection.
The evidence base
18 cited references.
Registered trials6
ClinicalTrials.gov · NA · RECRUITING · 2025-09-02
ClinicalTrials.gov · UNKNOWN · 2022-07-01
ClinicalTrials.gov · UNKNOWN · 2022-08-01
ClinicalTrials.gov · RECRUITING · 2002-01-15
ClinicalTrials.gov · COMPLETED · 2018-01-01
ClinicalTrials.gov · UNKNOWN · 2020-03-01
Indexed literature (PubMed)12
Burtscher J et al. · Aging Cell · 2023
Delgado-Peraza F et al. · Alzheimers Res Ther · 2023
Mendelsohn AR et al. · Rejuvenation Res · 2018
Thakur R et al. · Mol Neurobiol · 2025
Coradduzza D et al. · Biology (Basel) · 2023
Kal S et al. · Peptides · 2024
Matsuoka M et al. · Mol Neurobiol · 2010
Merry TL et al. · Am J Physiol Endocrinol Metab · 2020
Woodhead JST et al. · Biochim Biophys Acta Gen Subj · 2021
Karachaliou CE et al. · Biology (Basel) · 2023
Xiao J et al. · Growth Horm IGF Res · 2016
Li Y et al. · J Adv Res · 2024
Keep reading